Funding for this research was provided by:
Susan G Komen Foundation (PDF16378265)
National Cancer Institute (P50-CA58223)
Breast Cancer Research Foundation (RO1-CA148761, RO1-CA195740)
Susan G. Komen for the Cure (SAC-160074)
Received: 5 September 2018
Accepted: 8 November 2018
First Online: 30 November 2018
: All animal work was done under protocols approved by the University of North Carolina (UNC; Chapel Hill, NC) Institutional Animal Care and Use Committee.
: Not applicable.
: The following authors indicated a financial interest. Research support: none. Ownership: Charles M Perou, Bioclassifier, GeneCentric Diagnostics. Income: Charles M Perou, royalties from PAM50 breast cancer gene patent application and from lung gene signature patent. Intellectual Property: Charles M Perou, PAM50 breast cancer gene patent. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.